SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B. Czogalla, S. Schmitteckert, L. A. Houghton, G. S. Sayuk, M. Camilleri, A. Olivo-Diaz, R. Spiller, M. M. Wouters, G. Boeckxstaens, J. Lorenzo Bermejo, B. Niesler, A meta-analysis of immunogenetic Case–Control Association Studies in irritable bowel syndrome, Neurogastroenterology & Motility, 2015, 27, 5
  2. 2
    Bryon W. Petschow, Bruce P. Burnett, Audrey L. Shaw, Eric M. Weaver, Gerald L. Klein, Dietary Requirement for Serum-Derived Bovine Immunoglobulins in the Clinical Management of Patients with Enteropathy, Digestive Diseases and Sciences, 2015, 60, 1, 13

    CrossRef

  3. 3
    Emeran A. Mayer, Kirsten Tillisch, Arpana Gupta, Gut/brain axis and the microbiota, Journal of Clinical Investigation, 2015, 125, 3, 926

    CrossRef

  4. 4
    Mirjana Rajilić-Stojanović, Daisy M Jonkers, Anne Salonen, Kurt Hanevik, Jeroen Raes, Jonna Jalanka, Willem M de Vos, Chaysavanh Manichanh, Natasa Golic, Paul Enck, Elena Philippou, Fuad A Iraqi, Gerard Clarke, Robin C Spiller, John Penders, Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena?, The American Journal of Gastroenterology, 2015, 110, 2, 278

    CrossRef

  5. 5
    H-C Chang, A M-F Yen, J C-Y Fann, S Y-H Chiu, C-S Liao, H-H Chen, K-C Yang, L-S Chen, Y-M Lin, Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan, British Journal of Cancer, 2015, 112, 1, 171

    CrossRef

  6. 6
    Giovanni Dothel, Maria Raffaella Barbaro, Hélène Boudin, Valentina Vasina, Cesare Cremon, Luciana Gargano, Lara Bellacosa, Roberto De Giorgio, Catherine Le Berre-Scoul, Philippe Aubert, Michel Neunlist, Fabrizio De Ponti, Vincenzo Stanghellini, Giovanni Barbara, Nerve Fiber Outgrowth Is Increased in the Intestinal Mucosa of Patients With Irritable Bowel Syndrome, Gastroenterology, 2015, 148, 5, 1002

    CrossRef

  7. 7
    R. Vázquez-Frias, G. Gutiérrez-Reyes, M. Urbán-Reyes, N. Velázquez-Guadarrama, T.I. Fortoul-van der Goes, A. Reyes-López, A. Consuelo-Sánchez, Perfil de citocinas proinflamatorias y antiinflamatorias en pacientes pediátricos con síndrome de intestino irritable, Revista de Gastroenterología de México, 2015, 80, 1, 6

    CrossRef

  8. 8
    R. Vázquez-Frias, G. Gutiérrez-Reyes, M. Urbán-Reyes, N. Velázquez-Guadarrama, T.I. Fortoul-van der Goes, A. Reyes-López, A. Consuelo-Sánchez, Proinflammatory and anti-inflammatory cytokine profile in pediatric patients with irritable bowel syndrome, Revista de Gastroenterología de México (English Edition), 2015, 80, 1, 6

    CrossRef

  9. 9
    B. Coffin, Quoi de neuf sur les troubles fonctionnels intestinaux depuis la fin du dernier millénaire ?, Côlon & Rectum, 2015, 9, 1, 8

    CrossRef

  10. 10
    Emeran A. Mayer, Jennifer S. Labus, Kirsten Tillisch, Steven W. Cole, Pierre Baldi, Towards a systems view of IBS, Nature Reviews Gastroenterology & Hepatology, 2015,

    CrossRef

  11. 11
    Robert J. Shulman, Monica E. Jarrett, Kevin C. Cain, Elizabeth K. Broussard, Margaret M. Heitkemper, Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome, Journal of Gastroenterology, 2014, 49, 11, 1467

    CrossRef

  12. 12
    Emeran A. Mayer, Tor Savidge, Robert J. Shulman, Brain–Gut Microbiome Interactions and Functional Bowel Disorders, Gastroenterology, 2014, 146, 6, 1500

    CrossRef

  13. 13
    Robyn Nagel, Helle Bielefeldt-Ohmann, Rebecca Traub, Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients, Gut Pathogens, 2014, 6, 1, 34

    CrossRef

  14. 14
    J.-H. La, G. F. Gebhart, Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse, Neurogastroenterology & Motility, 2014, 26, 12
  15. 15
    Francisco A. Sylvester, Andrew Draghi, Antoine Menoret, Marina L. Fernandez, Zhu Wang, Anthony T. Vella, Distinctive Colonic Mucosal Cytokine Signature in New-Onset, Untreated Pediatric Crohn Disease, Journal of Pediatric Gastroenterology and Nutrition, 2014, 59, 5, 553

    CrossRef

  16. 16
    H. Lee, H. Chung, J. C. Park, S. K. Shin, S. K. lee, Y. C. Lee, Heterogeneity of mucosal mast cell infiltration in subgroups of patients with esophageal chest pain, Neurogastroenterology & Motility, 2014, 26, 6
  17. 17
    A. C. Ford, N. J. Talley, M. M. Walker, M. P. Jones, Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case–control study of 23 471 primary care patients, Alimentary Pharmacology & Therapeutics, 2014, 40, 7
  18. 18
    Giovanni Barbara, Cesare Cremon, Vincenzo Stanghellini, Inflammatory bowel disease and irritable bowel syndrome, Current Opinion in Gastroenterology, 2014, 30, 4, 352

    CrossRef

  19. 19
    Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja, Trygve Hausken, Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment, Expert Review of Gastroenterology & Hepatology, 2014, 8, 4, 435

    CrossRef

  20. 20
    Janos Feher, Erika Pinter, Illés Kovács, Zsuzsanna Helyes, Agnes Kemény, Adrienn Markovics, Rocco Plateroti, Aloisa Librando, Filippo Cruciani, Irritable Eye Syndrome: Neuroimmune Mechanisms and Benefits of Selected Nutrients, The Ocular Surface, 2014, 12, 2, 134

    CrossRef

  21. 21
    Max Schmulson, María Victoria Bielsa, Ramón Carmona-Sánchez, Angélica Hernández, Aurelio López-Colombo, Yolanda López Vidal, Mario Peláez-Luna, José María Remes-Troche, José Luis Tamayo, Miguel Angel Valdovinos, Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review, Revista de Gastroenterología de México (English Edition), 2014, 79, 2, 96

    CrossRef

  22. 22
    M. Schmulson, M.V. Bielsa, R. Carmona-Sánchez, A. Hernández, A. López-Colombo, Y. López Vidal, M. Peláez-Luna, J.M. Remes-Troche, J.L. Tamayo, M.A. Valdovinos, Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias, Revista de Gastroenterología de México, 2014, 79, 2, 96

    CrossRef

  23. 23
    G. Di Nardo, G. Barbara, S. Cucchiara, C. Cremon, R. J. Shulman, S. Isoldi, L. Zecchi, L. Drago, S. Oliva, R. Saulle, M. R. Barbaro, L. Stronati, Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS, Neurogastroenterology & Motility, 2014, 26, 2
  24. 24
    D. Keszthelyi, F. J. Troost, D. M. Jonkers, H. M. Eijk, P. J. Lindsey, J. Dekker, W. A. Buurman, A. A. M. Masclee, Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome, Alimentary Pharmacology & Therapeutics, 2014, 40, 4
  25. 25
    Mariella M. Self, Danita I. Czyzewski, Bruno P. Chumpitazi, Erica M. Weidler, Robert J. Shulman, Subtypes of Irritable Bowel Syndrome in Children and Adolescents, Clinical Gastroenterology and Hepatology, 2014, 12, 9, 1468

    CrossRef

  26. 26
    Vladimir Stanisic, Eamonn MM Quigley, The overlap between IBS and IBD – what is it and what does it mean?, Expert Review of Gastroenterology & Hepatology, 2014, 8, 2, 139

    CrossRef

  27. 27
    Y. Nasser, G. E. Boeckxstaens, M. M. Wouters, M. Schemann, S. Vanner, Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome, Neurogastroenterology & Motility, 2014, 26, 4
  28. You have free access to this content28
    M. Jovani, G. Fiorino, S. Danese, Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome, Alimentary Pharmacology & Therapeutics, 2013, 37, 2
  29. You have free access to this content29
    J. Matricon, Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome – author's reply, Alimentary Pharmacology & Therapeutics, 2013, 37, 2
  30. 30
    Alan G. Finkel, Juanita A. Yerry, J. Douglas Mann, Dietary Considerations in Migraine Management: Does a Consistent Diet Improve Migraine?, Current Pain and Headache Reports, 2013, 17, 11

    CrossRef

  31. 31
    Juan J. Sebastián Domingo, El síndrome del intestino irritable, ¿ya no debe ser considerado un trastorno funcional?, Medicina Clínica, 2013, 140, 9, 403

    CrossRef

  32. You have free access to this content32
    F. Karaahmet, Ö. Basar, I. Yksel, S. Coban, O. Yuksel, Letter: vitamin D supplementation and the irritable bowel syndrome, Alimentary Pharmacology & Therapeutics, 2013, 37, 4
  33. 33
    Won Sohn, Oh Young Lee, Sang Pyo Lee, Kang Nyeong Lee, Dae Won Jun, Hang Lak Lee, Byung Chul Yoon, Ho Soon Choi, Jongmin Sim, Ki-Seok Jang, Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea, Scandinavian Journal of Gastroenterology, 2013, 49, 1, 43

    CrossRef

  34. 34
    J. Matricon, E. Muller, A. Accarie, M. Meleine, M. Etienne, N. Voilley, J. Busserolles, A. Eschalier, M. Lazdunski, S. Bourdu, A. Gelot, D. Ardid, Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome, Neurogastroenterology & Motility, 2013, 25, 11
  35. 35
    Karin de Punder, Leo Pruimboom, The Dietary Intake of Wheat and other Cereal Grains and Their Role in Inflammation, Nutrients, 2013, 5, 3, 771

    CrossRef

  36. 36
    Ahmet Gurel, The role of oxidants and reactive nitrogen species in irritable bowel syndrome: A potential etiological explanation, Medical Science Monitor, 2013, 19, 762

    CrossRef

  37. 37
    Cristina Almansa, Lesley A Houghton, Irritable Bowel Syndrome: Diagnosis and Management, 2013,

    CrossRef